{"result": {"id": "1f93fe85-a2ca-45df-9dc6-011ce4ffd280", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>LOVASTATIN<|>ORGANIZATION<|>Lovastatin is a statin drug used to lower cholesterol by inhibiting its biosynthesis>  \n##  \n(\"entity\"<|>SIMVASTATIN<|>ORGANIZATION<|>Simvastatin, marketed as 'Zocor', is a statin medication that reduces LDL cholesterol and triglycerides>  \n##  \n(\"entity\"<|>PRAVASTATIN<|>ORGANIZATION<|>Pravastatin, sold as 'Pravachol', is a statin that lowers cholesterol and stabilizes plaque in arteries>  \n##  \n(\"entity\"<|>ATORVASTATIN<|>ORGANIZATION<|>Atorvastatin, branded as 'Lipitor', is a potent statin that reduces LDL cholesterol and cardiovascular risk>  \n##  \n(\"entity\"<|>CLOFIBRATE<|>ORGANIZATION<|>Clofibrate, also known as 'Atromid-S', is a fibrate drug that lowers triglycerides and VLDL cholesterol>  \n##  \n(\"relationship\"<|>LOVASTATIN<|>STATINS<|>Lovastatin is a member of the statins drug class<|>8>  \n##  \n(\"relationship\"<|>SIMVASTATIN<|>STATINS<|>Simvastatin is a member of the statins drug class<|>8>  \n##  \n(\"relationship\"<|>PRAVASTATIN<|>STATINS<|>Pravastatin is a member of the statins drug class<|>8>  \n##  \n(\"relationship\"<|>ATORVASTATIN<|>STATINS<|>Atorvastatin is a member of the statins drug class<|>8>  \n##  \n(\"relationship\"<|>CLOFIBRATE<|>FIBRATES<|>Clofibrate is a member of the fibrates drug class<|>8>  \n##  \n(\"relationship\"<|>STATINS<|>FIBRATES<|>Both statins and fibrates are lipid-lowering medications but work through different mechanisms<|>5>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166217, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 476, "prompt_tokens": 3021, "total_tokens": 3497, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2944}, "prompt_cache_hit_tokens": 2944, "prompt_cache_miss_tokens": 77}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 不能达到理想疗效。近年来发现的他汀类药，能阻抑胆固 醇的生物合成。单用他汀类药，或与胆酸螯合剂联用，对高胆固醇 血症有更明显的疗效。他汀类药是一类新颖的有希望的调节血脂 药，现有制剂有洛伐他汀、辛伐他汀（舒 降之）、普伐他汀（普拉 固）、阿托伐他汀（立普妥）等。\n（猿）烟酸及其衍生物\n　　员）烟酸：属 月族维生素。当用量超过作为维生素作用的剂量 时，可有明显的调节血脂的作用。烟酸调节血脂的疗效及剂量与 服药前的血脂水平有关，血脂水平异常较明显，服药剂量宜大，疗 效也更明显。\n　　　圆）阿西莫司：又名“氧甲吡嗪”、“乐脂平”。是一种新的人工 合成的烟酸衍生物，它的适用范围与烟酸相似，与烟酸相比，具有 抗脂肪分解作用的持续时间较长、效能较强等优点。\n　　猿）烟酸肌醇酯：是由 员分子肌醇与 远分子烟酸结合而成的酯。 该药从肠道吸收后在体内缓慢代谢，逐渐水解成烟酸和肌醇，然后 发挥作用。它能缓和与持久地扩张外周血管，改善脂质代谢，并有\n◆                                                                                                  摇猿\n\n\n\n\n\t 高脂血症防治      \n　溶解纤维蛋白、溶解血栓和抗凝血作用。其降低血脂的适应证与 烟酸相同。\n　　（源）贝 特 类 摇 氯 贝特，又名“氯 贝丁酯”、“安妥 明”、“冠心 平”，是这类药中应用最早的一种。它主要是通过抑制腺苷酸环 化酶，使脂肪细胞内环腺苷酸（糟粤酝孕）含量减少，抑制脂肪组织水 解，使血中非酯化脂肪酸含量减少，导致肝脏极低密度脂蛋白合成 及分泌减少。同时它可使脂蛋白酯酶的活性增强，加速极低密度 脂蛋白及三酰甘油的分解代谢。这些都使血中极低密度脂蛋白、 三酰甘油、低密度脂蛋白及总胆固醇的含量减少。另外，它还可通 过抑制肝细胞对胆固醇的合成及增加胆固醇从肠道的排泄，使血 中总胆固醇含量减少。\n　　近几年来，发现氯贝特的一些衍生物具有保持其调节血脂等 优点，而发生胆结石等不良反应明显减少。这些衍生物调节血脂 的能力和剂量差别较大。\n　　（缘）普罗布考摇普罗布考又名“丙丁酚”，有高度脂溶性，能在 脂肪组织中�\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>STATINS<|>ORGANIZATION<|>Statins are a class of drugs that inhibit cholesterol biosynthesis and are effective in treating hypercholesterolemia. Examples include Lovastatin, Simvastatin, Pravastatin, and Atorvastatin>  \n##  \n(\"entity\"<|>NIACIN<|>ORGANIZATION<|>Niacin is a B-vitamin that has significant lipid-regulating effects when used in doses higher than those required for its vitamin effects. Its efficacy and dosage depend on the initial lipid levels>  \n##  \n(\"entity\"<|>ACIPIMOX<|>ORGANIZATION<|>Acipimox, also known as 'Oxylytic Acid,' is a synthetic derivative of niacin with similar applications but longer-lasting and stronger anti-lipolytic effects>  \n##  \n(\"entity\"<|>INOSITOL NICOTINATE<|>ORGANIZATION<|>Inositol Nicotinate is an ester formed by one molecule of inositol and six molecules of niacin. It slowly metabolizes in the body, releasing niacin and inositol, and has lipid metabolism-improving and vasodilatory effects>  \n##  \n(\"entity\"<|>FIBRATES<|>ORGANIZATION<|>Fibrates, such as Clofibrate, inhibit adenylate cyclase, reduce fatty acid release, and enhance lipoprotein lipase activity, thereby reducing VLDL, triglycerides, LDL, and total cholesterol>  \n##  \n(\"entity\"<|>PROBUCOL<|>ORGANIZATION<|>Probucol, also known as 'Bifenabid,' is a highly lipophilic compound with lipid-regulating properties>  \n##  \n(\"relationship\"<|>STATINS<|>NIACIN<|>Both statins and niacin are used to regulate lipid levels, though they work through different mechanisms<|>5>  \n##  \n(\"relationship\"<|>ACIPIMOX<|>NIACIN<|>Acipimox is a synthetic derivative of niacin with enhanced effects<|>7>  \n##  \n(\"relationship\"<|>INOSITOL NICOTINATE<|>NIACIN<|>Inositol Nicotinate releases niacin upon metabolism, sharing similar lipid-regulating effects<|>6>  \n##  \n(\"relationship\"<|>FIBRATES<|>STATINS<|>Both fibrates and statins are used to treat hyperlipidemia but target different pathways<|>4>  \n##  \n(\"relationship\"<|>PROBUCOL<|>FIBRATES<|>Probucol and fibrates are both lipid-regulating agents, though their mechanisms differ<|>3>  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_13dcd7f396a118a723eb6632bde7fe57627cdfeb794a5b5fb551641667b7a4b7_v2"}